NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/02/2026
Back to search
Official data from USPTO
XERIS PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
XERIS PHARMACEUTICALS
ST13
US500000087450239Class
5
Filing
87450239
Registration
6059089
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
03/03/2026
Trademark type
Word
Nice classes
5
Filing date
05/15/2017
Registration date
05/19/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/04/2019
First use in commerce
11/04/2019
Drawing code
4
Owner type
03
Owner location
Chicago, IL, US
Examiner
SPARROW, MARY
Current location
Historical data usage
Holders and representatives
Holders
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc.
Representatives
Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseases and conditionsmetabolic and autoimmune diseases and conditions
Publications
History of USPTO decisions and trademark events.
54 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/02/2026
E815
TEAS SECTION 8 & 15 RECEIVED
11/24/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/19/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/23/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/19/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/22/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/22/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/22/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/22/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/22/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/15/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/14/2020
DOCK
ASSIGNED TO EXAMINER
04/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/27/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/13/2019
GNRT
NON-FINAL ACTION E-MAILED
12/13/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/13/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/12/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/12/2019
IUAF
USE AMENDMENT FILED
12/05/2019
EISU
TEAS STATEMENT OF USE RECEIVED
12/05/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/06/2019
EX3G
SOU EXTENSION 3 GRANTED
06/04/2019
EXT3
SOU EXTENSION 3 FILED
06/04/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/04/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/02/2018
EX2G
SOU EXTENSION 2 GRANTED
10/31/2018
EXT2
SOU EXTENSION 2 FILED
10/31/2018
EEXT
SOU TEAS EXTENSION RECEIVED
10/31/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/27/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/27/2018
DOCK
ASSIGNED TO EXAMINER
05/31/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/12/2018
EX1G
SOU EXTENSION 1 GRANTED
05/10/2018
EXT1
SOU EXTENSION 1 FILED
05/10/2018
EEXT
SOU TEAS EXTENSION RECEIVED
05/10/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/05/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2017
PUBO
PUBLISHED FOR OPPOSITION
10/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/21/2017
ALIE
ASSIGNED TO LIE
08/21/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/21/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/21/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/21/2017
DOCK
ASSIGNED TO EXAMINER
08/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2017
NWAP
NEW APPLICATION ENTERED
05/18/2017
Continuous trademark protection
Get notified about every new filing that threatens XERIS PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.